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SUMMARY 
 
Acot7, encoding acyl-CoA thioesterase-7, is one of ~60 genes expressed ubiquitously across 
tissues but relatively silenced, or “disallowed”, in pancreatic β-cells. The capacity of ACOT7 
to hydrolyse long-chain acyl-CoA esters suggests potential roles in β-oxidation, lipid 
biosynthesis, signal transduction or insulin exocytosis. Here, we explored the physiological 
relevance of β-cell-specific Acot7 silencing by re-expressing ACOT7 in these cells. ACOT7 
overexpression in clonal MIN6 and INS1(832/13) β-cells impaired insulin secretion in 
response to glucose plus fatty acids. Furthermore, examined in a panel of transgenic mouse 
lines, we demonstrate that overexpression of mitochondrial ACOT7 selectively in the adult β-
cell reduced glucose tolerance dose-dependently and impaired glucose-stimulated insulin 
secretion. By contrast, depolarisation-induced secretion was unaffected, arguing against a 
direct action on the exocytotic machinery. Acyl-CoA levels, ATP/ADP increases, membrane 
depolarization and Ca
2+
 fluxes were all markedly reduced in transgenic mouse islets, whereas 
glucose-induced O2-consumption was unchanged. Whilst glucose-induced increases in 
ATP/ADP ratio were similarly lowered after ACOT7 over-expression in INS1(832/13) cells, 
changes in mitochondrial membrane potential () were unaffected, consistent with an 
action of Acot7 to increase cellular ATP consumption. Since Acot7 mRNA levels are 
increased in human islets in type 2 diabetes, inhibition of the enzyme might provide a novel 
therapeutic strategy.  
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INTRODUCTION 
 
Maintained secretion of insulin is essential for normal blood glucose homeostasis and both 
the loss and dysfunction of pancreatic β-cells, the sole source of the circulating hormone in 
man, are implicated in Type 2 diabetes (T2D) (1). 
 
Glucose sensing by β-cells involves a number of gene products such as GLUT2 and 
glucokinase whose expression is restricted to these, and only a few other, cell types and that 
ensure that elevated blood glucose concentrations are converted into enhanced glycolytic, and 
then citrate cycle flux, stimulating respiratory chain activity and, ultimately, ATP production 
by mitochondria. The resulting rise in cytosolic ATP/ADP ratio closes ATP-sensitive K
+
 
(KATP) channels and this in turn leads to plasma membrane depolarisation and Ca
2+
 influx 
through voltage-gated calcium channels, triggering dense core secretory granule exocytosis 
(1).  
In addition to β-cell “signature” genes, a small group of “housekeeping” genes is also 
relatively repressed in β- compared to other cell types (2-4). Of these, the monocarboxylate 
(lactate/pyruvate) transporter MCT-1 (SLC16A1) and lactate dehydrogenase (LDH) are 
particularly weakly expressed in the β-cell, but strongly expressed elsewhere in the body(5). 
This configuration appears to prevent inappropriate insulin secretion in response to 
circulating pyruvate derived from muscle during exercise(5-7). Thus, patients with activating 
mutations in the SLC16A1 promoter display exercise-induced hyperinsulinism (6), a situation 
mimicked in mice by over-expression of MCT-1 selectively in the adult β-cell(7). Systematic 
comparisons of the transcriptome of mouse islets versus other tissues (2; 3) revealed a further 
64 genes similarly suppressed (or “disallowed”) in β-cells, of which a core of 11 genes (4) 
4 
 
were common to two independent studies. Whilst evidence exists for a role for the 
suppression of some of these genes in the function or survival of β-cells (notably MCT-1, as 
described above, as well as LDHA (8) and PDGFRA (9)), for the remainder, the biological 
rationale for β-cell-selective repression is obscure (4) . 
 
Acyl-CoA thioesterase 7 (Acot7) has been   recently identified by our group as a member of 
the β-cell “disallowed” genes group (3). ACOT7 is a member of a family of 13 enzymes 
responsible for the hydrolysis of acyl-CoA (10; 11). The murine Acot7 gene comprises 13 
exons and undergoes differential splicing to generate cytosolic and mitochondrial variants 
(12).  ACOT7 acts upon acyl-CoAs with a range of chain lengths (10) and is particularly 
highly expressed in the brain and testis (12; 13). Additionally, ACOT7 is implicated in the 
hydrolysis of arachidonoyl-CoA (AA-CoA) (14), which furnishes free arachidonic acid (AA) 
for the synthesis of prostaglandins. Others (13; 15) have suggested a role for ACOT7 in the 
brain in the maintenance of low, non-toxic, acyl-CoA levels. 
 
Suggesting a role in β-cell decompensation in T2D, levels of Acot7 are increased in Zucker 
diabetic fatty rat islets (16) and in micro-dissected β-cell enriched tissue from T2D patients 
(17). Given the importance of intracellular lipids in the control of many β-cell functions, 
including membrane trafficking, ion channel activity and insulin exocytosis (18), we have 
explored here the impact of Acot7 overexpression in these cells both in vitro and in vivo.  
 
EXPERIMENTAL DESIGN AND MATERIALS 
Generation of constructs over-expressing ACOT7 isoforms 
The murine Acot7 coding sequences (CDS) were amplified by RT-PCR from liver and kidney 
RNA and ligated into P3XFLAG-CMV-14 in-frame with the C-terminal 3xFLAG epitope 
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tag. The CDS of each isoform, complete with epitope tag, were then amplified and ligated 
into the pBI-L vector generating two plasmids with a bidirectional tetracycline-regulated 
promoter that simultaneously drives the expression of both firefly luciferase and 
Flag:Acot7_mit (pBI-LTet FLAG::Acot7_mit) or Flag:Acot7_cyt (pBI-LTet 
FLAG::Acot7_cyt). 
 
Generation and maintenance of Acot7 transgenic (Acot7 Tg) mice. 
The expression cassette was excised from pBI-LTet FLAG::Acot7_mitand used for 
pronuclear microinjection into C57BL/6J oocytes at the Imperial College London/MRC 
transgenics unit. Successful integrants (F9, F15 and F26) were identified by PCR and 
backcrossed with C57BL/6 wild-type mice for at least 3 generations. The resulting 
heterozygous Acot7_mit mice were crossed with homozygous RIP7-rtTA mice (C57BL/6 
background) to produce littermates Acot7 Tg (Acot7_mit
+/-
, Rip7rtTA positive, heterozygous, 
1:2 ratio) and controls (Acot7_mit
-/-
, Rip7rtTA positive, heterozygous, 1:2 ratio). All the 
animals were administered doxycycline in the drinking water (0.5 g/l) from the age of 5 
weeks. High-fat diet (HFD, DIO Rodent Purified Diet w/60% Energy From Fat, DIO-58Y1) 
was administered from the age of 5 weeks, when indicated. 
All in vivo procedures were performed at the Imperial College Central Biomedical Service 
and approved by the UK Home Office Animals Scientific Procedures Act, 1986 (PPL 
70/7349).  
 
Acot7 expression and protein analysis 
RNA-Seq read data were downloaded for a range of mouse tissues (Accession numbers: 
SRA056174 – beta cells; GSE21860 – islets; GSE36026 – other tissues). Reads were mapped 
to the mouse genome (Ensembl NCBIM37) using Bowtie:Tophat, and genes quantified with 
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Cufflinks (19). Isolation of total RNA, RT-qPCR and Western (immuno-)blotting were 
performed as previously described (20).  
 
Human growth hormone (hGH) release assay 
hGH secretion assays were performed as previously described (21). To reach a final 
experimental concentration of 0.5 mM, 2:1 unsaturated:saturated, mix of fatty acids, which in 
the presence of 1% BSA results in unbound FFA concentrations in the nanomolar range (22), 
oleate and palmitate (Sigma-Aldrich) were incubated with BSA for 2h at 37C.  
 
Immunocytochemistry and Immunohistochemistry  
MIN6 and INS1(832/13) cells, co-transfected with pTet-off and pBI-LAcot7_mit or pBI-L-
Acot7_cyt, and isolated pancreata were fixed, stained and visualized as previously described 
(23). Cells and slides were visualized using a LSM-780 microscope (Zeiss, UK) and  an 
Axiovert 200 M microscope (Zeiss, Welwyn Garden City, UK), respectively. ImageJ 
software (Wayne Rasband, NIMH) was used to calculate the mean intensity of flag (Acot7 
transgene) in the β-cell area surrounded by glucagon-positive (alpha-cell) area. For β-cell 
mass estimation, we determined the percentage of pancreatic surface which was insulin–
positive, as measured in whole pancreas sections separated by 25μm in the z-axis.  
 
Intraperitoneal glucose (IPGTT), insulin (IPITT) tolerance tests and in vivo Insulin 
secretion  
IPGTT and IPITT were performed as described in (20). For IS, animals were fasted overnight 
and glucose (3g/kg) was administered intraperitoneally. Plasma insulin was measured by 
ELISA (Crystal Chem). 
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Isolation and analysis of mouse islets  
Islets were isolated by digestion with collagenase as described elsewhere (24). Insulin 
secretion, Ca
2+
 (Fluo-2-AM, Invitrogen) and ATP/ADP (Perceval) imaging were performed 
as previously described (23; 25). Insulin release during perifusion was monitored using a 
custom-built device, using 50 islets and perifusion rate of 500 µl min
-1
 at 37 °C. Insulin was 
quantified using a homogeneous time-resolved fluorescence-based (HTRF)assay (CisBio) in 
a Pherastar Reader (BMG Labtech).  
 
Electrophysiology was performed as described in (26) in perforated patch-clamp 
configuration using an EPC9 patch-clamp amplifier controlled by Pulse acquisition software 
(Heka Elektronik, Pfalz, Germany). Data were filtered at 1 kHz and sampled at 2 kHz.  
 
Seahorse experiments were performed as described in (27). Briefly, 50 islets per well 
(matched size) were placed in 24-well islet plates in Krebs-Ringer buffer-0.1% BSA 
containing 3mM glucose and pre-incubated at 37C without CO2 for 1h. Islets were then 
incubated at 3mM glucose followed by 17mM glucose and oligomycin (5μM) to measure 
oxygen consumption rate (OCR) and extracellular acidification rate (ECAR).  
 
Transfection, ATP/ADP and Δψm analysis in INS1 (832/13) cells 
Cells were transfected for 24 h with pBI-LTet FLAG::Acot7_mit or a control empty vector 
plus pEGFP-C1 (Addgene) (secretion and TMRE experiments) or GW1-PercevalHR 
(Addgene, ATP/ADP experiments, ratiometric mode) using Lipofectamine2000, with 50-
60% efficiency. Cells were pre-incubated for 1h at 3mM glucose prior to stimulation. 
ATP/ADP and tetramethylrhodamine-ethyl ester (TMRE) dynamics were monitored using a 
widefield microscope (Olympus IX70) equipped with a Polychrome IV (Till), a heating stage 
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and 40x/1.35NA objective. ATP/ADP measurements were performed as previously described 
(28). For TMRE experiments, INS1 (832/13) were loaded with 10nM TMRE in imaging 
buffer (28) for 45 min. and re-equilibrated with 2nM for 10 min. before recordings. TMRE 
(2nM) was present throughout, and excited at 550nm (0.25 Hz). Data were analysed using 
ImageJ with a purpose-designed macro. 
 
Lipidomics 
Lipids extraction from isolated islets (150-300 per animal and sample) and analysis was 
conducted by the Lipidomics Facility at Babraham Institute (29). 
 
Statistical analysis 
Statistical analysis was performed with GraphPad Prism 6.0. Statistical significance was 
evaluated as indicated in the figure legends. All data are shown as mean ± standard error of 
the mean (S.E.M.). P values < 0.05 were considered statistically significant. 
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RESULTS 
 
Acot7 expression is weak in mouse islets compared with other tissues.  
Interrogation of publicly-accessible RNA-Seq databases (Fig. 1A), and qRT-PCR (Fig. 1B), 
confirmed lower levels of mRNA encoding all Acot7 mRNA variants in mouse islets 
compared to all other tissues examined. Notably, RNA-Seq data showed lowest Acot7 
expression in purified β-cells (Fig 1A). Western blotting analysis confirmed strongest 
expression at the protein level in brain, lung and testis. ACOT7 immunoreactivity was 
undetectable in islets (Fig. 1C). As observed by relative RT-qPCR, other members of the 
Acyl-CoA thioesterase family were also poorly expressed in mouse islets (Fig. 1D). 
 
Overexpression of Acot7 in β-cell lines impairs glucose plus fatty acid-induced insulin 
secretion. 
We first determined whether Acot7 overexpression may affect glucose-stimulated insulin 
secretion (GSIS) or secretion in response to depolarisation of the plasma membrane with KCl 
(KSIS). We generated two DNA constructs expressing the cytosolic (Acot7_cyt) or the 
mitochondrially-targeted (Acot7_mit) isoforms. Experiments were performed using either 
isoform co-overexpressed in β-cell lines alongside human growth hormone as a reporter of 
regulated secretion from the transfected cell population.  The latter peptide is co-stored and 
released with insulin from dense core granules (21).  
 
Both Acot7_cyt and Acot7_mit were expressed with the appropriate sub-cellular localisation 
in both murine MIN6 (30) and in INS1(832/13) (31) cells (Fig. 2A). Thus, in each case, the 
epitope tag displayed a cytosolic localisation (Acot7_cyt) or was closely co-localised with the 
mitochondrial marker TOM20 (Acot7_mit; Fig. 2A).  
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Examined in MIN6 cells, overexpression of neither isoform affected hormone release in 
response to 30 vs 3mM glucose, nor in response to 30mM KCl (Fig. 2B). However, since 
Acot7 action is likely to lead to the degradation of acyl-CoA derived from exogenous fatty 
acids (FAs) we next asked whether secretion in response to a mixture of glucose plus FAs 
may be susceptible to Acot7 overexpression. Confirming this possibility, secretion in 
response to 20mM glucose plus a mixture of palmitate and oleic acid (0.5mM Oleate:Palmitic 
acid (2:1) / 1% (w/v) BSA), was significantly reduced in MIN6 and in INS1(832/13) cells 
upon over-expression of either the cytosolic (16% and 13%, respectively) or mitochondrial 
isoforms of Acot7 (17% and 13% in respectively) (Fig. 2C).  
 
β-cell-selective over-expression of mitochondrial Acot7 in adult mice impairs glucose 
tolerance. 
To explore the potential role in vivo for the suppression of insulin release identified above in 
clonal β-cells, we generated three mouse lines re-expressing the mitochondrial form of Acot7 
using the TetON system (32). Our in vitro results suggested that both isoforms inhibited 
secretory function to a similar extent but, given the central role of mitochondria in β-cell 
stimulus-secretion coupling (1) we focussed on mitochondrial ACOT7.  
 
Genomic qPCR analysis demonstrated the presence of 4, 7 and 70 copies of the transgene in 
three lines originating from three different founders (F) (F9, F26 and F15 respectively; results 
not shown). After establishing stable integration at a single site by the inheritance of the same 
number of copies for 3 generations, offspring were subsequently crossed to RIP7rtTA mice, 
expressing the reverse tetracyclin-regulated transactivator selectively in β-cells (32). Islets 
isolated from animals bearing or lacking the Acot7 transgene were incubated with 
doxycycline for 48h to induce the expression of the transgene. Alternatively, animals were 
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administered doxycycline for 2-4 weeks to induce expression before islet isolation. RT-qPCR 
revealed an increase of ~14, 28 and 100-fold over endogenous Acot7 mRNA levels 
respectively in the three lines (F15, F9 and F26) when doxycyline was administered in vivo, 
with comparable levels of induction observed in vitro in cultured islets (Fig. 3A). By contrast, 
Acot7 mRNA levels remained unchanged in the hypothalamus (a potential site of RIP2 
activity (33)) or the liver of the mice with maximum Acot7 overexpression in islets (F26) 
(Fig. S1A). Additionally, the ratio of Acot7:β-actin mRNA in islets from mice displaying the 
strongest over-expression of the thioesterase in islets (F26) was in the same range as that 
observed in hypothalamus (Fig. S1B), indicating that levels of over-expression in β-cells 
were still within the normal physiological range in the context of other cell types. Expression 
of the other Acot family members was identical in transgenic versus control islets, 
eliminating the possibility of compensatory changes in the expression of the latter (Fig S1C). 
 
Measurements of expression by Western blotting confirmed a degree of induction of Acot7 in 
the three lines essentially proportional to changes at the mRNA level (Fig. 3B). 
Immunocytochemical analysis of pancreata revealed immunoreactivity corresponding to the 
incorporated FLAG tag within the islets in lines F9 and F26 (Fig. 3C, D). Immunoreactivity 
was below the level of detection in pancreata from F15 mice (Fig. 3C, D). Examined in the 
most strongly-expressing line F26, the pattern of immunoreactivity was punctate, consistent 
with mitochondrial targeting, and was exclusively restricted to the insulin-positive β-cell 
population (Fig. 3E). We did notice that whereas there was little inter-animal variation in 
expression levels in animals from lines F26 and F15, F9 offspring expressed Acot7 at highly 
variable levels (both for mRNA and protein). The reasons for this variability are unclear. 
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Animals from line F26 displayed indistinguishable weight gain and random-fed glycaemia 
compared to wild-type littermates (Fig. S2). However, intraperitoneal glucose tolerance was 
significantly impaired in the transgenic animals at 17, 21 and 25 weeks, with females 
showing a stronger phenotype (Fig. 4A, B). Similar, but less marked changes were also 
obtained for lines F15 and F9 (Fig. S3).  
 
To determine whether the effects on glucose tolerance in Acot7 transgenic line F26 (Acot7 
Tg) may be further exacerbated during β-cell stress, we maintained these mice on a high fat 
diet (HFD, 60% total calories) for 4 weeks (34), sufficient to engender insulin resistance and 
significant increases in peak glycemia in control non-transgenic mice of the same age (Fig. 
4C, D). Differences in glucose tolerance between non-transgenic animals and transgenic 
littermates became apparent in younger animals (9 weeks) under these conditions than on 
normal chow (in which the phenotype wasn’t observed until the age of 17 weeks, 12 for the 
females), especially in male mice (Fig 4A). Comparable results were obtained for the lines 
with F15 and F9 (Fig. S3). Whether examined in animals on a HFD or regular chow, the 
observed defects in glucose tolerance were milder in mice from line F15, with lowest Acot7 
expression, indicating a dose-dependent effect of Acot7 over-expression. 
 
To exclude insulin insensitivity as the cause of the glucose intolerance detected in Acot7 Tg 
mice, we evaluated insulin tolerance in 9-week-old F26 female mice fed a HFD and 25-week-
old F15 female mice fed a Chow diet (Fig. S4A). No differences between transgenic and 
control mice were observed (Fig. S4A). β-cell mass was also similar for control and 
transgenic mice from line F26 kept on chow or HFD (Fig. S4B, C). 
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Over-expression of mitochondrial Acot7 in the β-cell impairs glucose-induced increases 
in cytosolic ATP/ADP ratio, membrane depolarization, free Ca
2+
 and insulin secretion 
To explore the mechanism(s) underlying the glucose intolerance after Acot7 overexpression, 
we measured plasma insulin levels in fasted F26 mice (previously kept on regular chow or 
HF diet). This revealed a non-significant tendency towards elevated insulin levels in Acot7 
Tg mice versus littermate controls but, strikingly, no further increase in plasma insulin was 
observed post glucose (3g/kg) challenge (Fig. 5A). This result indicates a reduced capacity of 
the β-cells to secrete insulin in response to increased glucose concentration. Consistent with 
this in vivo observation, insulin secretion from transgenic mouse isolated islets revealed a 
marked inhibition in release in response to 17 mM glucose or 8 mM glucose plus fatty acids 
versus non-transgenic islets (Fig. 5B). As observed in MIN6 cells (Fig. 2B), no differences in 
insulin secretion were detected in response to depolarization of the plasma membrane with 
KCl (Fig. 5C).  
 
In contrast to our observations in β-cell lines, Acot7 overexpression reduced secretion in 
response to high glucose even in the absence of supplementation with exogenous FA. 
Suggesting that the requirement for exogenous FAs may reflect a depletion of endogenous 
lipid stores after 24 h, INS1(832/13) cells expressing mitochondrial Acot7, and then pre-
cultured for 1h in 3mM glucose, displayed lower insulin secretion in response to 17 mM 
glucose than control plasmid-transfected cells (Fig. 6A).  
 
Dynamic measurements of insulin secretion in transgenic islets revealed changes in both 
phases of secretion in response to high glucose, with the second (sustained) phase being 
particularly strongly inhibited (Fig. 5D, E).  
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The above observations suggested that signalling by glucose to exocytosis (1) may become 
defective in Acot7 Tg β-cells. To test this hypothesis, we measured the metabolic response to 
high glucose by following changes in the cytosolic ATP/ADP ratio with the recombinant 
fluorescent probe, Perceval (35; 36). The glucose-mediated ATP/ADP rise, largely reflective 
of changes in β-cells (rather than other cell types), was strongly reduced in Acot7 transgenic 
islets versus controls (Fig 7A). We also assessed ATP/ADP changes in INS1(832/13) cells 
using the ratiometric sensor Perceval HR in order to provide a measure of this ratio which 
was independent of the level of probe expression (37).  Over-expression of Acot7 had no 
effect on basal ATP/ADP ratios but significantly lowered the speed and extent of the 
ATP/ADP increases in response to 17mM glucose. By contrast, glucose-induced increases in 
mitochondrial membrane potential (), assessed with TMRE, were identical in each case. 
 
 
Correspondingly, glucose-induced changes in intracellular free cytosolic Ca
2+
, imaged with 
the intracellular fluorescent dye, Fluo-2-AM (38), were also significantly reduced in Acot7 
Tg islets (Fig. 7B) consistent with impaired downstream closure of KATP channels (39) (40). 
The aforementioned defects were not explained by changes in the expression of genes 
essential for GSIS, including the glucose transporter GLUT2 (Slc2a2), glucokinase (Gck), the 
KATP channel subunits Kir6.2 (Kcnj11) and SUR1 (Abcc8) or the ATP synthase ATP5 
(Atp5a1) in Acot7 Tg islets (Fig. S5).   
 
To investigate a direct role for defective KATP channel closure we used perforated patch 
clamp electrophysiology (41)  to measure changes in membrane potential in single β-cells. 
These experiments were performed using animals maintained on a high fat diet for 4 weeks 
where differences in glucose tolerance between transgenic and wild-type were already 
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apparent (see above and Fig 4). Transgenic β-cells showed significantly weaker membrane 
depolarization in response to high glucose than those from control mice (Fig. 7C), as 
expected if a reduction in the closure of KATP channels occurs as a consequence of lowered 
ATP/ADP increase (Fig. 7A). 
 
In order to shed more light into the mechanisms underlying the lowered ATP/ADP increases 
after Acot7 over-expression, we assessed mitochondrial oxidative metabolism upstream of 
ATP generation. Monitored using a Seahorse XF analyser, no significant differences in 
oxygen consumption (OCR) were observed between control and transgenic islets (Fig. 7D) 
though a tendency was observed towards higher basal OCR in transgenic islets.  This 
difference persisted in the presence of oligomycin, an inhibitor of ATP synthase, arguing 
against increased uncoupling in transgenic islets. Interestingly, the fold increase in OCR in 
response to 17 mM glucose (% of basal, Fig. 7E) tended to be lower in transgenic islets. 
Although not significantly different, the rate of extracellular acidification (ECAR) tended to 
be higher in Acot7 Tg islets at high glucose, possibly reflecting a tendency towards increases 
in lactate dehydrogenase (Ldha), though not Slc16a1 (MCT-1), expression (Fig S6A).  
 
Over-expression of Acot7 in β-cells results in reduced fatty-acyl-CoA generation but not 
in significantly altered fatty acid levels 
To determine whether an action of ACOT7 to hydrolyse FA-CoA esters into free FA (FFA) 
and CoA (42) might contribute to impaired metabolic signalling, we performed a complete 
lipidomic profiling of islets isolated from transgenic or control mice maintained on a HFD for 
4 weeks using Electrospray Ionisation Mass Spectrometry (ESI-MS). Islets were incubated 
overnight at 11mM glucose, starved (3mM glucose) for 1h and subsequently incubated at 
high glucose (17mM) for 30 min. A clear reduction in FA-CoA was observed in Acot7 Tg 
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islets, as expected (Fig. 8A, C). A tendency towards an increase in the levels of fatty acids of 
a particular chain length, notably C18:1 (most probably, oleic acid), was also detected (Fig. 
8B). No significant changes were observed in the levels of monoacylglycerol (MAG), 
diacylglycerol (DAG), or other lipids (Fig. 8A). A strong tendency (p=0.06) towards 
increased fatty acyl carnitine (FaCN) levels was also observed in transgenic islets.  
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DISCUSSION 
 
Although at least 11 genes are selectively repressed in the β-cell (4), the physiological 
relevance, if any, of this tissue-specific suppression has only been examined for Ldha (8), 
Slc16a1 (MCT1)(7) and Pdgfra (9). Here, we show firstly, using overexpression in β-cell 
lines, that low ACOT7 levels are required for normal secretory responses to glucose in the 
presence of adequate FA levels. Extending these data to the in vivo setting, we also 
demonstrate that β-cell specific over-expression in mice of mitochondrial ACOT7 causes a 
marked and dose-dependent impairment in glucose tolerance that reflects altered β-cell 
function rather than reduced β-cell mass (43). No direct evidence was obtained for changes in 
insulin sensitivity in this model, though clamp studies would be needed to exclude this 
possibility entirely. 
 
Insulin secretion in response to glucose (and glucose plus FA) was strongly impaired in 
Acot7 Tg mouse islets, likely explaining the impairment in glucose tolerance and insulin 
secretion observed in vivo. Although only islets over-expressing the mitochondrial isoform of 
Acot7 were interrogated, increased levels of fatty acyl-carnitine in transgenic islets suggest 
increased shuttling of acyl-CoA into the mitochondria in this model expected to result in a 
decrease of cytosolic FA-CoA.  
 
Consistent with our results, Klett et al. (44) found that siRNA-mediated reduction of Acsl4 
(Acyl-CoA synthetase isoform 4), responsible for the conversion of certain FA into FA-CoA, 
reduced insulin secretion in response to glucose and, more markedly, glucose plus FA in 
INS1(832/13) cells. In contrast with our findings, and suggesting a different underlying 
mechanism, the effects occurred without changes in acyl-CoA species. On the contrary, Acsl4 
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depletion resulted in reduced epoxyeicosatrienoic acids. Although measurement of 
eicosanoids in transgenic islets would be necessary to discard their contribution to the 
observed phenotype in Acot7 Tg mice, Acsl4 inhibition also affected KCl-mediated insulin 
secretion whereas ACOT7 overexpression did not. Furthermore, Ellis and colleagues did not 
observe changes in prostaglandin D2 or E2 in Acot7-depleted brains (15) nor, more 
surprisingly, in acyl-CoAs levels. Thus, lipid composition and availability may be critical 
determinants of Acot7 action in different cell types (45).  
 
FA-CoA has been shown to modulate GSIS through a range of different mechanisms, 
including the control of secretory granules exocytosis, protein acylation and modulation of 
the ATP-sensitivity of KATP
 
channels (45). Most recently, Prentki and colleagues (18) have 
provided evidence that MAGs may play a particularly important role in stimulus-secretion 
coupling in β-cells, possibly acting via Munc13-1 to enhance a late event in exocytosis 
downstream of cytosolic Ca
2+
 increases.  In the present study, we did not observe an effect of 
ACOT7 overexpression on depolarisation-stimulated secretion, nor did we observe 
significant differences in the levels of MAG arguing against a role for Acot7 in MAG-
dependent regulation of GSIS. Of note, ACOT7 overexpression reduced both phases of GSIS, 
arguing against a preferential effect on a plasma membrane-proximal, readily-releasable 
granule pool (46).   
 
On the other hand, we did observe a strong reduction in glucose-mediated ATP/ADP and 
Ca
2+
 rises in Acot7 Tg animals, suggesting that low ACOT7 levels are necessary to ensure 
effective KATP channel closure. The exact mechanism(s) underlying the impaired ATP/ADP 
increases remains unclear. However, preserved OCR rates in islets (Fig. 5D), and 
mitochondrial  glucose-mediated increases (Fig. 6C) in INS1(832/13) cells after Acot7 
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over-expression lend weight to the view that increased ATP consumption, rather than 
impaired mitochondrial ATP generation is involved. This may conceivably involve a futile 
cycle wherein increased acyl-CoA synthesis, occurs in the face of accelerated breakdown of 
this lipid. Consistent with this view, secretion stimulated by glutamine plus leucine, which 
allows flux into the TCA cycle downstream of citrate, was slightly reduced in INS1(832/13) 
cells over-expressing Acot7 (Fig S6B). Further analysis will be needed, however, to 
determine whether this reflects enhanced acyl-CoA breakdown/resynthesis.  
  
Interestingly, all members of the Acot family were poorly expressed in mouse islets, stressing 
the importance of maintaining acyl-CoA hydrolysis to a minimum in these cells. Of note, 
expression of Acot7 is up-regulated in the islet in Zucker diabetic fatty (ZDF) rat (16) and in 
β-cell-enriched microdissected tissue from T2D patients (17). Pharmacotherapeutic 
approaches which correct this defect might thus be useful in some forms of T2D. 
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FIGURE LEGENDS 
 
Figure 1. Acot7 expression is weak in mouse islets in comparison to other tissues. A) 
RNA-seq data for Acot7 in different mice tissues and isolated islets and β-cells. FKPM: 
Fragments per kilobase pero million fragments mapped. B) RT-qPCR expression data of 
Acot7 mRNA in mice tissues and isolated islets. n=3 C57BL6 mice. C) Western blot for 
ACOT7 in mouse tissues and islets. A representative experiment is shown. D) RT-qPCR 
expression of Acot family members (Acot1-13) in isolated mouse islets. Data are presented as 
relative to Actin. n= 4 mice per genotype. 
 
Figure 2. Overexpression of Acot7 in β-cell lines impairs glucose plus fatty acid-induced 
insulin secretion. A) Immunocytochemistry using an anti-Flag antibody to show the 
localization of Acot7_mit and Acot_cyt in MIN6 or INS1(832/13) cells. Cells were 
transfected with vectors encoding an Acot7 transcript containing or not a mitochondrial 
targeting sequence (Acot7_mit and Acot7_cyt, respectively) and including a 3xFLAG tag. An 
antibody against TOM20C was used as mitochondrial outer membrane marker. Objective 
100x/NA 1.4. B, C) Glucose-stimulated secretion was evaluated in MIN6 (B, C) and 
INS1(832/13) (C)  cells over-expressing cytosolic (Acot7_cyt), mitochondrial (Acot7_mit) 
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Acot7 or an empty vector using over-expressed human growth hormone (hGH) as insulin 
surrogate. hGH secretion was measured after 1h 17/20mM glucose stimulation in presence or 
absence of 0.5mM fatty acids as indicated (G: Glucose; PA: Palmitic Acid; OA: Oleic Acid, 
PA/OA ratio 1:2), following o/n pre-incubation at 3mM glucose. Data are from three to four 
independent experiments and six to eight technical replicates (means ± S.E.M). ns no 
significant, *p<0.05, **p<0.01, ****p<0.0001; Matched (by experimental day) two-way 
ANOVA, Bonferroni test.  
 
Figure 3. Generation of mice with β-cell-selective over-expression of mitochondrial 
Acot7. A) Expression of Acot7 mRNA in isolated islets from different Acot7 Tg lines (F15, 
F9, F26) assessed by RT-qPCR. Isolated islets were incubated for 48h in the presence of 
doxycycline (Dox-In vitro) or administered in the drinking water to animals for 2-4 weeks 
(Dox- In  vivo). n=4-7 mice/genotype. Data are presented as fold-change versus the Dox-In 
vitro control. *p<0.05, ****p<0.0001; Unpaired Student’s t test. B) Western blot for ACOT7 
(anti-Acot7) or exogenous ACOT7 (anti-Flag) in isolated islets from F15, F9 and F26 mouse 
lines. Tubulin is shown as loading control. A representative experiment is presented. C) 
Immunocytochemistry using anti-Flag antibody to show the expression of exogenous 
mitochondrial Acot7 (Acot7_mit) in pancreata from control or Acot7 Tg mice (lines F15, F9, 
F26). An anti-glucagon antibody was used for alpha cells staining. Representative islets are 
shown. Objective 63X/NA 1.4. D) ImageJ software was used to quantify maximum 
fluorescence intensity of Flag staining in C). n=3-5 mice/genotype; 2 pancreas sections per 
animal were used, separated by 50μm. **p<0.01, ****p<0.0001; Unpaired student t test. E) 
As in C, including an anti-insulin antibody to show co-localization of Acot7_mit and Insulin.  
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Figure 4. β-cell-selective over-expression of mitochondrial Acot7 impairs glucose 
tolerance. Glucose tolerance was measured in male (A, C) and female (B, D) Acot7 Tg 
(green) and littermate control (black) mice of the indicated age. Mice were maintained on a 
normal chow diet (A, B) or fed a high fat-diet (C, D) for 4 weeks. The area under the curve 
(AUC) is shown underneath each graph. N=8-10 mice/genotype. *p<0.05, **p<0.01, 
***p<0.001 ****p<0.0001; analysis by two-way ANOVA (repeated measures) Fisher least 
significance different test (Glucose tolerance test); Student’s t test (AUC).  
 
Figure 5. Over-expression of mitochondrial Acot7 in the β-cell impairs glucose-induced 
insulin secretion in vivo and in vitro. A) Glucose (3g/kg)- induced insulin secretion was 
assessed in Acot7 Tg (green) and littermate control (black) mice fed a normal diet (left hand 
panel, 23 week-old, n=7M+6F C, 6F+6M Acot7 Tg) or a high-fat diet (right hand panel, 9 
week-old, n=6M C, 10M Acot7 Tg), as indicated. Upper graphs show absolute insulin 
measurements (ng/ml). Insulin levels are presented as fold change over the basal level (time 
0) on the lower panels. Matched two-way ANOVA, Bonferroni test. . The statistical test was 
applied to assess the effect of glucose injection on blood insulin content over the time in 
control (black lines, **p<0.01 , ****p<0.0001 ) and Acot7 Tg animals (green lines, ns: non-
significant) B, C) Insulin secretion was evaluated in islets isolated from Acot7 Tg (green) or 
control (black) 25-week old female mice (fed a chow diet) in response to 30 min exposure to 
the indicated concentrations of glucose (G) in the presence or absence of 0.5mM fatty acids 
(FA; 2:1 palmitate/oleic acid) (B) or KCl (C), following 1h pre-incubation at 3mM glucose.  
Data are from three independent experiments and nine (B) or six (C) technical replicates 
(means ± S.E.M.). ns: non-significant, *p<0.05; Matched two-way ANOVA, Bonferroni test. 
D) Following 1h of pre-incubation at 3mM glucose, 50 Acot7 Tg (green) or control (black) 
isolated islets were perifused with KHB buffer containing 17mM glucose during 30 min. 
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Secreted insulin was measured in samples taken periodically every 30s. n= 5 
animals/genotype (3 male, 2 female/genotype, 25 week-old, fed a chow diet). E) Area under 
the curve (AUC) 0-30, 0-10 and 10-30 min after addition of 17mM glucose. *p<0.05; 
Unpaired student’s t test. 
 
Figure 6. Overexpression of Acot7 in INS1 (832/13) cells impairs glucose-induced insulin 
secretion and increases in cytosolic ATP/ADP ratio. A) Glucose-stimulated insulin 
secretion was evaluated in INS1(832/13) cells over-expressing mitochondrial Acot7 (Acot7) 
or an empty vector (C). Insulin secretion was measured after a 30min. stimulation at 3 or 
17mM glucose. (G: Glucose). Data are from three independent experiments and six technical 
replicates (means ± S.E.M). *p<0.05. Matched two-way ANOVA, Bonferroni test B, C) 
INS1(832/13) cells were co-transfected with a construct expressing mitochondrial Acot7 
(Acot7) or an empty vector (C) and a PercevalHR-containing plasmid to monitor changes in 
ATP/ADP ratio in response to high glucose (17mM vs 3mM). Data are from two independent 
experiments and 113 C and 90 Acot7 individual cells. In (B) traces represent the F480/F440 
fluorescence ratio. Mean fluorescence and rate of fluorescence increase (slope) at 3mM 
glucose (min. 0-3) and 17mM glucose (initial response, min. 3-8 and late response, min. 8-
20) were estimated and are presented as mean of the values ± S.E.M. *p<0.05, 
****p<0.0001; Unpaired student’s t test. In (C), traces represent normalized (to basal) and 
mean fluorescence intensity (F/F0) over time. Maximum fold change and area under the 
curve (AUC) were determined and presented as mean of the values ± S.E.M. ***p<0.001, 
****p<0.0001; Unpaired student’s t test. (D) INS1(832/13) cells were co-transfected with a 
construct expressing mitochondrial Acot7 (Acot7) or an empty vector and a GFP-expressing 
vector to allow selection of transfected cells. Cells were stained with  TMRE (sensitive to 
changes in Δψm) and perifused with 3mM or 17mM glucose as indicated. Data are from three 
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independent experiments and 160 C and 166 Acot7, GFP-positive cells. Traces represent 
normalized (to basal) and mean fluorescence intensity (F/F0) over time. Maximum fold 
change and area under the curve (AUC) were determined and presented as mean of the values 
± S.E.M. ns: no significant. Unpaired student’s t test.All the experiments were performed 24h 
after cell transfection and the cells were pre-incubated at 3mM glucose during 1h before 
starting the experiments. 
 
Figure 7. Over-expression of mitochondrial Acot7 in the β-cell impairs glucose-induced 
increases in cytosolic ATP/ADP ratio, membrane depolarization and free Ca
2+
. A) Intact 
Acot7 Tg (green) and control (black) islets were infected with an adenoviral Perceval sensor 
construct to monitor changes in ATP/ADP ratio in response to high glucose (17mM vs 
3mM)., following 1h preincubation at 3mM glucose. n=34 islets (from 4 Control mice, 2M, 
2F)/ 30 islets (from 4 Acot7 Tg mice, 2M, 2F). B) Intact Acot7 Tg (green) and control (black) 
islets were incubated for 45 min with 10 μM Fluo-2-AM in KHB buffer (3mM glucose) 
before imaging to monitor Ca
2+
 entry in response to high (17mM) glucose. n=55 islets (from 
8 Control mice (4M, 4F))/ 71 islets (from 9 Acot7 Tg mice (4M, 5F). Mice (F26) were 25 
weeks old and kept on a normal chow diet. No differences associated with the sex of the 
animals were observed. Traces represent normalized and averaged fluorescence intensity 
(F/F0) over time. Maximum fold change and area under the curve (AUC) were determined 
and presented on the right hand side as mean of the values ± S.E.M. *p<0.05, **<0.01, 
***p<0.001; Unpaired student’s t test. C) Representative current clamp recordings of isolated 
β-cells from control (black) and Acot7 transgenic mice (green) in response to 3 and 17 mM 
glucose application. The graph on the right hand side shows mean membrane potential ± 
S.E.M. n=6-11 single cells per genotype. Mice (F26, male) were 9 weeks old fed a HFD for 4 
weeks. D, E) OCR and F) ECAR were measured in the presence of 3mM or 17mM glucose 
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and 5μM oligomycin (OM) over time as indicated. In (E) data are presented as fold induction 
over the basal OCR shown in (D). Each plot represent the mean of 6 (control, two different 
animals) and 12 (Acot7 Tg, four animals) wells with 70 islets. Maximum fold change and 
area under the curve (AUC) were determined and presented as mean of the values ± S.E.M. 
Unpaired student’s t test. Mice (F15) were 25 weeks old and kept on a normal chow diet. 
 
Figure 8. Over-expression of Acot7 in β-cells results in reduced fatty-acyl-CoA 
generation but not fatty acid levels. A) Total lyso-phosphatidic acid (LPA), phosphatidic 
acid (PA), lyso-phosphatidylcholine (LPC), acyl-linked phosphatidycholine (aPC), 
phosphatidycholine (PC), acyl-lyso-phosphatidylethanolamine (aLPE), lyso-
phosphatidylethanolamine (LPE), acyl-phosphatidylethanolamine (aPE), 
phosphatidylethanolamine (PE), lyso-phosphatidylglycerol (LPG), phosphatidylglycerol 
(PG), lyso-phosphatidylinositol (LPI), phosphatidylinositol (PI), lyso-phosphatidylserine 
(LPS), phosphatidylserine (LPS), cardiolipin (CL), free fatty acids (FFA), fatty acyl CoA 
(FaCoA), fatty acyl carnitine (FaCN), monoacylglycerol (MG), diacylglycerol (DG), 
triacylglycerol (TG), sphingosine (SG), sphindogsine-1-phosphate (S1P), ceramide (Cer), 
sphingomyelin (SM), were analysed in isolated islets from 9-week old Acot7 Tg (green) or 
control littermantes (C, black) fed on a high fat diet for 4 weeks. B, C, D) Detailed free fatty 
acid (FA, (B)), fatty acyl-CoA (FaCoA, (C)) and fatty acyl-carnitine (FaCN, (D)) content in 
Acot7 Tg and control islets. n=3-5 mice/genotype, 150-350 islets/mice. Mice (male) were 9 
week old and kept on high fat diet for 4 weeks. Isolated islets were pre-incubated at 3mM 
glucose during 1h and stimulated with 17mM glucose during 30 min prior snap-freezing.  
Data represent mean values ± S.E.M. *p<0.05; Unpaired Student’s t test. 
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SUPPLEMENTAL FIGURE LEGENDS 
Figure S1. Acot7 expression remains unchanged in hypothalamus and liver of Acot7 
Tg mice and the expression of other members of the family is identical in Acot7 
transgenic islets than control. A,B) RT-qPCR expression data of Acot7 mRNA in 
hypothalamus, liver and isolated islets from Acot7 Tg (line F26) (green) and littermate 
controls (black). Data (mean ± S.E.M) is presented as fold change versus control (A) or 
relative to actin (B). n=4-5 mice/genotype (each dot represents an individual mouse). C) RT-
qPCR was used to evaluate the expression of the indicated Acot family members. n=4 
mice/genotype. Data (mean ± S.E.M) presented as fold change versus control. 
Figure S2. Acot7 over-expression does not affect body weight or randomly-fed 
glycemia. Body weight (left hand panels) and randomly-fed glycaemia (right hand panels) 
were periodically monitored in Acot7 Tg mice (Line F26; green lines) and littermate controls 
(black lines) following the beginning of the Doxycycline treatment (5 weeks old). n=8-10. ns: 
non-significant. Student t-test corrected for multiple comparisons by the Sidak-Bonferroni 
method. 
Figure S3. β-cell-selective over-expression of mitochondrial Acot7 impairs glucose 
tolerance (Lines F15 and F9). A) Glucose tolerance was measured in 25 week old female 
mice from Acot7 Tg lines F15 (left) or F9 (right) fed a regular chow diet. B) Glucose 
tolerance was measured in 9 week old male mice from Acot7 Tg lines F15 (left) or F9 (right) 
fed a high fat diet during 4 weeks. Acot7 Tg are shown in green and littermate controls in 
black. The area under the curve (AUC) is shown underneath each graph. n=5-8 
mice/genotype. ns: non-significant, *p<0.05, **p<0.01; Two-way ANOVA Fisher least 
significance different test (Glucose tolerance test); Student’s t test (AUC). 
Figure S4. Over-expression of Acot7 does not affect insulin resistance and β-cell 
mass. A) Insulin tolerance was measured in 9 week-old females Acot7 Tg (green) or 
littermate control (black) mice (line F26) fed a high-fat diet (left panel) and 25 week-old 
females Acot7 Tg (green) or control (black) (line F15) fed a chow diet (right hand-side 
graph). n=5-6 mice/genotype (left), 3-4 (right).B, C) Pancreata from Acot7 Tg (F26) and 
littermate control mice fed a normal diet ((B), 25 week-old) or a high-fat diet ((C), 9 week-
old), as indicated were fixed and subjected to immunocytochemical analysis for insulin and 
glucagon, as indicated. Representative islets are shown on the left. Scale bar: 50μm. 
ImageJ software was used to quantify β-cell mass which is presented as a percentage of the 
pancreatic surface and corresponds to quantification of the insulin-positive area per 
pancreas area quantified in whole pancreas sections. n=6 mice/genotype (3 male,3 female 
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each); 2 pancreas sections per animal were used, separated by 50μm. ns: non-significant; 
Unpaired Student’s t test. 
Figure S5. The expression of genes essential for GSIS remained unchanged upon 
ACOT7 over-expression in islets. RT-qPCR was used to evaluate the expression of the 
indicated genes in isolated islets from Acot7 Tg (F26) (green) and littermate controls (black). 
Data (mean ± S.E.M) presented as fold change versus control. n=4 mice/genotype. 
Figure S6. A) The expression of Ldha and Slc16a1 remained unchanged upon ACOT7 
over-expression in islets. RT-qPCR was used to evaluate the expression of Ldha and 
Slc16a1 in isolated islets from Acot7 Tg (F15 and F26, as indicated) (green) and littermate 
controls (black). Data (mean ± S.E.M) presented as fold change versus control. n=8-10 
mice/genotype. B) Overexpression of Acot7 in INS1 (832/13) cells impairs leucine plus 
glutamine-induced insulin secretion. Leucine plus glutamine-stimulated insulin secretion 
was evaluated in INS1(832/13) cells over-expressing mitochondrial Acot7 (Acot7) or an 
empty vector (C). Insulin secretion was measured after a 30min. stimulation at 3mM glucose 
(G: Glucose) alone or in the presence of 10mM leucine (Leu) and 10mM glutamine (Gln). 
Data are from four independent experiments and eight technical replicates (means ± S.E.M). 
*p<0.05. Matched two-way ANOVA, Bonferroni test. The experiments were performed 24h 
after cell transfection and the cells were pre-incubated at 3mM glucose during 1h before 
starting the experiments. 
 
 
 













